echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Nat Med: Studying data from nearly 35,000 COVID patients identified four main symptom patterns for COVID growth

    Nat Med: Studying data from nearly 35,000 COVID patients identified four main symptom patterns for COVID growth

    • Last Update: 2023-02-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    In a new study, researchers from research institutions such as Weill Cornell Medical College in the United States found that there are four main subtypes of post-COVID syndrome called long COVID, defined by different symptom groups
    .
    The findings were recently published in
    the journal Nature Medicine as "Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes.
    "



    The new study is the largest
    of its kind to explore the long coronavirus.
    The authors used a machine learning algorithm to find symptom patterns
    in the health records of nearly 35,000 U.
    S.
    patients who tested positive for COVID infection and later developed lingering long COVID symptoms.


    The new study, funded by the National Institutes of Health's (NIH) "Researching COVID to Enhance Recovery (RECOVER) program, is part of a year-long $9.
    8 million grant focused on the Electronic Health Record Cohort Study, spearheaded by Dr.
    Rainu Kaushal, senior associate dean for clinical research and chair of the Department of Population Health Sciences at Weill Cornell Medical School


    Kaushal said, "The purpose of RECOVER is to quickly clarify what happened
    in the long COVID.
    Study how cases are classified to influence patient outcomes and care
    .


    Of the four main symptom patterns detected, one pattern was characterized by heart and kidney problems, including patients with a relatively high proportion of infections in the first months of the COVID-19 pandemic in the United States; Another pattern includes respiratory problems, anxiety, sleep disturbances, and other symptoms, including headaches and chest pain; Nearly two-thirds of patients with this pattern are women
    .


    Corresponding author Fei Wang, Ph.
    D.
    , associate professor in the Department of Population Health Sciences at Weill Cornell Medical School, said, "These results should inform ongoing research on the potential mechanisms and potential treatments for the long new crown
    .


    Viral infections sometimes leave patients with a variety of lingering, often non-specific symptoms
    .
    For SARS-CoV-2, post-infection syndrome is commonly referred to as long COVID, and more formally referred to as "Post-Acute Sequelae of SARS-Cov-2 Infection (PASC)"
    .
    They seem to be very common; It is estimated that Americans with COVID make up to 40%
    of the U.
    S.
    adult population.


    "Understanding the epidemiology of COVID enables clinicians to help patients understand their symptoms and prognosis, and to facilitate multidisciplinary treatment
    of patients," Kaushal said.
    Electronic health records provide a window into this situation, allowing us to better characterize COVID symptoms and inform other types of research
    , including basic findings and clinical trials.


    The health records analyzed in the new study came from two large datasets collected by the National Patient-Centered Clinical Research Network (PCORnet), a consortium
    of eight medical institutions from across the United States 。 One dataset comes from Kaushal-led INSIGHT Clinical Research Network, which includes data from patients in New York, while the other comes from the OneFlorida+ network, which includes patients
    from Florida, Georgia and Alabama.
    Overall, the analysis covers the health records
    of 34,605 different patients from March 2020 to November 2021 and does not include the first wave of Omicron.


    Data management and subphenotypic analysis pipelines
    .
    Image from Nature Medicine, 2022, doi:10.
    1038/s41591-022-02116-3
    .


    When initially analyzing the dataset of New York patients, this machine learning algorithm detected four main symptom patterns
    .
    The first symptom pattern, which accounts for about 34% of patients, is dominated
    by cardiac, renal, and circulatory symptoms.
    Compared to the other groups, patients in this group were older on average (median age 65 years), more likely to be male (49%), had relatively high rates of COVID-19 hospitalizations (61%), and had relatively high pre-existing conditions
    .
    This group also had the highest percentage (37%)
    of the first wave of SARS-CoV-2 infections in the United States from March to June 2020.


    The second symptom pattern, comparable in frequency to the first (33% of patients), was mainly breathing and sleep problems, anxiety, headaches, and chest pain
    .
    Patients with this symptom pattern were mostly women (63%), with a median age of 51 years and a much lower rate of COVID-19 hospitalizations (31%)
    .
    In late-stage outbreaks from November 2020 to November 2021, almost two-thirds of patients in this group tested positive
    for SARS-CoV-2.
    The upfront symptoms in this group of patients centered on respiratory problems, such as chronic obstructive pulmonary disease and asthma
    .


    The remaining two symptom patterns were dominated by musculoskeletal and neurological symptoms, including arthritis (23% of patients), and a combination of gastrointestinal and respiratory symptoms (10%)
    .


    Only in the first symptom pattern did the sex ratio roughly 1 to 1; Of the other three symptom patterns, women accounted for a significant proportion (more than 60%)
    .


    Dr Wang said, "This gender gap in long COVID risk is consistent with previous studies, but so far few studies have attempted to reveal the mechanisms
    behind it.


    To validate their findings, the authors applied their algorithm to a dataset covering patients in three southern states of the United States (Florida, Georgia, and Alabama) and found very similar
    results.
    The analysis also supports the overall effectiveness of Long Covid, as it shows that for patients who test negative for SARS-CoV-2, there is no such clear pattern
    of symptoms at the same time interval between 30 and 180 days after testing.


    The authors are currently conducting follow-up research along several routes, including defining symptom patterns for COVID so that risk factors for different symptom patterns can be easily identified from electronic health records, and leveraging existing treatments to help patients
    with COVID growth.


    Resources:

    1.
    Hao Zhang et al.
    Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes.
    Nature Medicine, 2022, doi:10.
    1038/s41591-022-02116-3.

    2.
    Study identifies four major subtypes of long COVID
    https://medicalxpress.
    com/news/2023-01-major-subtypes-covid.
    html

    Source: | Biovalley
    edited | Swagpp


    Click "Read Original" below to download the Mace Medical APP!

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.